Vivace Therapeutics

About:

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

Website: http://vivacetherapeutics.com

Top Investors: RA Capital Management, Mission BioCapital, Sequoia Capital, Canaan Partners, Boxer Capital

Description:

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.

Total Funding Amount:

$70M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Mateo, California, United States

Founded Date:

2014-01-01

Contact Email:

Info(AT)vivacetherapeutics.com

Founders:

Sofie Qiao

Number of Employees:

1-10

Last Funding Date:

2020-12-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai